搜索





搜索





Biodexa Pharmaceuticals PLC

BDRX

添加自选

0.681USD

+0.001+0.15%

收盘 09-22 16:00（美东）

700.82K总市值

3.88市盈率 TTM

盘前交易 08:24 (美东)0.680USD-0.001-0.15%

Biodexa Pharmaceuticals PLC

0.681

+0.001+0.15%

财务摘要利润表资产负债表现金流量表公司收入财报公司估值风险评估

概览

新闻分析

财务

股票评分

技术分析

预测

持股情况

股息

公司资料

财务摘要利润表资产负债表现金流量表公司收入财报公司估值风险评估

BDRX 利润表

您可以在这里找到Biodexa Pharmaceuticals PLC的年度或季度收入报告，以深入了解Biodexa Pharmaceuticals PLC的运营、管理效率和表现。

单季报

单季报+年报

单季报

年报

YOY

隐藏空白行

FY2025H2

FY2024H2

FY2024H1

FY2023H2

FY2023H1

FY2022H2

FY2022H1

FY2021H2

FY2021H1

FY2020H2

FY2020H1

FY2019H2

FY2019H1

FY2018H2

FY2018H1

FY2017H2

FY2017H1

FY2016H2

FY2016H1

FY2015H2

FY2015H1

FY2014H2

FY2014H1

FY2013H2

FY2013H1

营业总收入

----

-100.00%0.00

-63.11%67.09K

-41.49%237.39K

29.19%181.89K

39.04%405.72K

11.13%140.79K

122.38%291.81K

-30.44%126.68K

-64.33%131.22K

-83.08%182.13K

-12.35%367.87K

190.87%1.08M

19.26%419.72K

-85.24%370.18K

-87.70%351.93K

240.63%2.51M

1262.44%2.86M

810.34%736.36K

813.19%210.06K

3064.73%80.89K

-74.83%23.00K

--2.56K

--91.37K

营业收入

----

-100.00%0.00

-63.11%67.09K

-41.49%237.39K

29.19%181.89K

39.04%405.72K

11.13%140.79K

122.38%291.81K

-30.44%126.68K

-64.33%131.22K

-83.08%182.13K

-12.35%367.87K

190.87%1.08M

19.26%419.72K

-85.24%370.18K

-87.70%351.93K

240.63%2.51M

1262.44%2.86M

810.34%736.36K

813.19%210.06K

37.60%80.89K

-34.55%23.00K

--58.79K

--35.14K

主营业务成本

----

-698.31%-293.43K

--776.64K

--49.04K

----

营业费用

----

22.15%3.80M

-13.00%3.15M

-26.55%3.11M

-1.70%3.62M

35.26%4.24M

39.16%3.68M

5.82%3.13M

-51.07%2.65M

-42.65%2.96M

16.63%5.41M

-3.90%5.17M

-11.08%4.64M

32.40%5.38M

-1.40%5.21M

-57.77%4.06M

-50.31%5.29M

57.66%9.61M

193.57%10.64M

35.69%6.10M

81.68%3.62M

580.13%4.49M

-13.57%1.99M

--660.70K

--2.31M

研发费用

----

69.16%2.48M

-9.00%1.63M

-30.90%1.47M

-14.28%1.79M

1.01%2.12M

43.02%2.09M

39.74%2.10M

-53.05%1.46M

-58.16%1.50M

10.67%3.12M

-2.61%3.60M

-19.86%2.82M

23.80%3.69M

13.20%3.51M

-19.96%2.98M

101.36%3.10M

29.81%3.73M

30.47%1.54M

2.77%2.87M

46.72%1.18M

824.32%2.79M

-13.22%805.11K

--302.24K

--927.80K

折旧摊销及损耗

----

-20.28%90.21K

-11.01%101.38K

-9.04%113.17K

-27.80%113.92K

-30.18%124.41K

21.13%157.78K

-61.78%178.17K

-70.90%130.26K

-11.35%466.19K

-14.61%447.55K

29.96%525.88K

-26.12%524.13K

-55.97%404.65K

-25.45%709.48K

-48.13%919.00K

-41.21%951.64K

363.18%1.77M

1207.21%1.62M

164.93%382.54K

82.83%123.83K

270.46%144.39K

-43.01%67.73K

--38.98K

--118.85K

其他营业费用

----

-109.43%-23.70K

----

-139.54%-11.32K

100.00%0.00

-184.85%-4.72K

38.51%-13.87K

164.10%5.57K

---22.56K

29.41%-8.69K

----

---12.31K

----

营业利润

----

-24.83%-3.80M

6.89%-3.15M

24.91%-3.05M

-3.22%-3.38M

-35.55%-4.06M

-39.17%-3.28M

-5.59%-2.99M

55.39%-2.35M

43.10%-2.84M

-23.60%-5.28M

-15.93%-4.98M

10.97%-4.27M

-16.50%-4.30M

2.87%-4.79M

48.07%-3.69M

36.55%-4.94M

-32.53%-7.11M

-127.81%-7.78M

-21.49%-5.36M

-73.14%-3.41M

-570.48%-4.41M

11.04%-1.97M

---658.15K

---2.22M

净非营业利息收入（费用）

利息收入

----

54.42%61.16K

235.31%64.11K

118.71%39.61K

267.56%19.12K

--18.11K

--5.20K

-100.00%0.00

-98.38%6.52K

-4.03%781.07

51864.07%402.82K

6.45%813.87

-99.73%775.19

-92.66%764.53

-37.44%287.68K

-98.19%10.42K

-60.53%459.84K

3071.33%575.71K

28948.81%1.17M

1320.51%18.15K

-98.54%4.01K

--1.28K

--275.40K

----

利息费用

----

-50.22%7.65K

-53.21%8.20K

-32.74%15.36K

-15.77%17.53K

24.82%22.83K

29.96%20.81K

2427.22%18.29K

-6.83%16.01K

-99.16%723.90

31.96%17.18K

-67.98%86.14K

-92.90%13.02K

681.14%268.99K

304.27%183.49K

-41.32%34.44K

--45.39K

--58.69K

----

-86.47%7.78K

-80.71%47.46K

--57.51K

--246.01K

----

出售证券收益

----

-1112.00%-81.80K

---26.84K

--8.08K

----

100.26%795.42

----

-2399.67%-301.87K

----

--13.13K

--6.51K

----

--4.90K

----

---274.76K

特殊收入（费用）

----

2210.17%1.89M

82.06%559.82K

48.12%81.64K

-10.88%307.50K

-93.52%55.12K

453.84%345.04K

191.49%851.10K

98.87%-97.51K

---930.22K

---8.66M

--0.00

----

100.00%0.00

----

88.27%-1.08M

----

---9.18M

----

-固定资产出售收益

----

89.16%3.06K

----

-82.89%1.62K

-100.00%0.00

114.14%9.45K

-94.33%1.73K

---66.82K

--30.56K

----

其他非经营性收入（费用）

----

-89.16%-3.06K

----

82.89%-1.62K

100.00%0.00

-114.14%-9.45K

94.33%-1.73K

--66.82K

---30.56K

----

税前利润

----

33.65%-1.95M

16.69%-2.56M

26.81%-2.93M

-4.28%-3.07M

-85.52%-4.01M

-19.41%-2.95M

46.81%-2.16M

82.32%-2.47M

12.71%-4.06M

-226.40%-13.95M

-1.90%-4.65M

14.12%-4.27M

-1.20%-4.57M

-0.12%-4.98M

71.58%-4.51M

30.99%-4.97M

-278.87%-15.88M

-111.59%-7.20M

5.95%-4.19M

-67.83%-3.40M

-608.73%-4.46M

18.59%-2.03M

---628.75K

---2.49M

所得税

----

-0.19%-95.57K

59.39%-93.18K

75.53%-95.38K

21.47%-229.43K

-19.51%-389.76K

-70.12%-292.15K

46.50%-326.12K

49.91%-171.74K

22.04%-609.53K

49.36%-342.89K

11.76%-781.85K

0.37%-677.14K

-98.88%-886.05K

-41.84%-679.66K

92.89%-445.51K

53.35%-479.17K

-1051.13%-6.27M

-345.06%-1.03M

-26.84%-544.38K

3.93%-230.81K

-104.77%-429.17K

20.17%-240.26K

---209.58K

---300.96K

除税后利润

----

34.78%-1.85M

13.24%-2.47M

21.56%-2.84M

-7.11%-2.84M

-97.25%-3.62M

-15.62%-2.65M

46.87%-1.83M

83.13%-2.30M

10.83%-3.45M

-278.32%-13.61M

-5.19%-3.87M

16.30%-3.60M

9.50%-3.68M

4.33%-4.30M

57.69%-4.07M

27.27%-4.49M

-163.59%-9.61M

-94.60%-6.17M

9.44%-3.65M

-77.47%-3.17M

-860.71%-4.03M

18.38%-1.79M

---419.17K

---2.19M

持续经营利润

----

34.78%-1.85M

13.24%-2.47M

21.56%-2.84M

-7.11%-2.84M

-97.25%-3.62M

-15.62%-2.65M

46.87%-1.83M

83.13%-2.30M

10.83%-3.45M

-278.32%-13.61M

-5.19%-3.87M

16.30%-3.60M

9.50%-3.68M

4.33%-4.30M

57.69%-4.07M

27.27%-4.49M

-163.59%-9.61M

-94.60%-6.17M

9.44%-3.65M

-77.47%-3.17M

-860.71%-4.03M

18.38%-1.79M

---419.17K

---2.19M

停止经营利润

----

--0.00

----

100.00%0.00

----

-188.62%-776.93K

100.00%0.00

189.79%876.74K

-98.55%-4.43M

---976.40K

---2.23M

----

归属于母公司的净利润

----

34.78%-1.85M

13.24%-2.47M

21.56%-2.84M

-7.11%-2.84M

-97.25%-3.62M

-15.62%-2.65M

46.87%-1.83M

83.13%-2.30M

25.73%-3.45M

-278.32%-13.61M

-65.79%-4.65M

58.78%-3.60M

44.41%-2.80M

-29.81%-8.73M

47.53%-5.04M

-8.86%-6.72M

-163.59%-9.61M

-94.60%-6.17M

9.44%-3.65M

-77.47%-3.17M

-860.71%-4.03M

18.38%-1.79M

---419.17K

---2.19M

归属于普通股东的净利润

----

34.78%-1.85M

13.24%-2.47M

21.56%-2.84M

-7.11%-2.84M

-97.25%-3.62M

-15.62%-2.65M

46.87%-1.83M

83.13%-2.30M

25.73%-3.45M

-278.32%-13.61M

-65.79%-4.65M

58.78%-3.60M

44.41%-2.80M

-29.81%-8.73M

47.53%-5.04M

-8.86%-6.72M

-163.59%-9.61M

-94.60%-6.17M

9.44%-3.65M

-77.47%-3.17M

-860.71%-4.03M

18.38%-1.79M

---419.17K

---2.19M

基本每股收益

99.44%0.00

96.85%0.00

100.00%0.00

99.98%-0.01

-8438.71%-46.01

-15457.63%-58.36

25.69%-0.54

68.28%-0.38

92.73%-0.73

72.56%-1.18

-736.52%-9.97

90.60%-4.31

99.17%-1.19

50.98%-45.84

-3.49%-142.84

62.38%-93.51

25.18%-138.03

-95.32%-248.54

-61.64%-184.49

65.44%-127.25

54.57%-114.13

-2341.66%-368.20

-218.83%-251.25

---15.08

---78.81

稀释每股收益

99.44%0.00

96.85%0.00

100.00%0.00

99.98%-0.01

-8438.71%-46.01

-15457.63%-58.36

25.69%-0.54

68.28%-0.38

92.73%-0.73

72.56%-1.18

-736.52%-9.97

90.60%-4.31

99.17%-1.19

50.98%-45.84

-3.49%-142.84

62.38%-93.51

25.18%-138.03

-95.32%-248.54

-61.64%-184.49

65.44%-127.25

54.57%-114.13

-2341.66%-368.20

-218.83%-251.25

---15.08

---78.81

每股派息

----

--0.00

货币单位

--USD

审计意见

----

常见问题

如何在 TradingKey 上查看 Biodexa Pharmaceuticals PLC 的利润表？



先看总营收，再依次查看营收成本、毛利润、营业费用、营业利润、税前利润、净利润和每股收益（EPS）。营收反映公司的业务规模，而各项利润和利润率则体现公司能否有效地将营收转化为盈利。

季度利润表和年度利润表有什么区别？



季度利润表反映公司在一个为期三个月的财务季度内的经营表现，年度利润表则汇总整个财年的业绩。季度数据适合用于观察近期发展势头和季节性变化，年度数据则更适合评估长期增长、盈利能力和业务周期。

利润表页面中的同比是什么意思？



同比是指将某项财务指标与上年同期进行比较，例如将本季度营收与去年同一季度的营收进行对比。同比数据有助于投资者观察增长趋势，同时减少正常季节性变化对分析的影响。

分析 BDRX 股票时，哪些利润表指标最重要？



重要的指标包括营收增长、毛利润、毛利率、营业利润、营业利润率、净利润、每股收益、研发费用、销售及管理费用以及所得税费用。投资者通常会综合分析这些指标，以判断公司是否正在增长、有效控制成本并提升盈利能力。

Biodexa Pharmaceuticals PLC 全年的净利润是多少？



Biodexa Pharmaceuticals PLC 2025 财年净利润为 -4.82M。

Biodexa Pharmaceuticals PLC 年度营业利润是多少？



Biodexa Pharmaceuticals PLC 2025 财年的营业利润为 -11.46M。

每股收益与利润表有什么关系？



每股收益（EPS）通常以净利润除以流通在外的股份数量计算，用于衡量公司平均每股创造的利润。分析 EPS 时，还应结合股本变化、利润率、现金流和估值指标进行综合判断。